8a537b1e-3937-467b-b258-8ed4ddae6550 - samples

ABSTRACT: RRBS data from TRACERx non-small cell lung cancer (NSCLC) tumours and matched normal adjacent tissue. TRACERx (TRAcking Cancer Evolution through therapy (Rx)) is a prospective cohort study designed to investigate intratumor heterogeneity (ITH) in relation to clinical outcome, and to determine the clonal nature of driver events and evolutionary processes in early stage non-small cell lung cancer (NSCLC).

PROVIDER: EGAD00001009707 | EGA |

REPOSITORIES: EGA